Centric Pharma Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Centric Pharma Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gagga Kommareddy and Dileep Nuthaki serve as directors at the Company.
- CIN/LLPIN
U24230TG2022PTC158867
- Company No.
158867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Centric Pharma Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagga Kommareddy  | Director | 08-Sep-2023 | Current |
| Dileep Nuthaki | Director | 08-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Centric Pharma Life Sciences.
Enhance accessibility to Centric Pharma Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Centric Pharma Life Sciences?
Unlock access to Centric Pharma Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Geometric Results International India Private LimitedActive 13 years 14 daysGagga Kommareddy is a mutual person
Gagga Software Solutions Private LimitedActive 1 year 8 monthsGagga Kommareddy and Dileep Nuthaki are mutual person
- Boggavarapu Consultancy Services Private LimitedActive 1 year 5 months
Dileep Nuthaki is a mutual person
- Kommareddy Tax Consultancy Services Private LimitedActive 6 years 16 days
Dileep Nuthaki is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Centric Pharma Life Sciences?
Centric Pharma Life Sciences has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centric Pharma Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centric Pharma Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
